Tirasemtiv enhances submaximal muscle tension in an Acta1 :p.Asp286Gly mouse model of nemaline myopathy
Journal of General Physiology · 2024
DOI: 10.1085/jgp.202313471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Physiology, 2024. Verfasst von Ricardo A Galli und 11 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC Location Vrije Universiteit Amsterdam, Physiology , Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Myopathies, Nemaline, Imidazoles, Pyrazines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: Netherlands Organisation for Health Research and Development.
Abstract (Originalsprache)
Nemaline myopathies are the most common form of congenital myopathies. Variants in ACTA1 (NEM3) comprise 15–25% of all nemaline myopathy cases. Patients harboring variants in ACTA1 present with a heterogeneous disease course characterized by stable or progressive muscle weakness and, in severe cases, respiratory failure and death. To date, no specific treatments are available. Since NEM3 is an actin-based thin filament disease, we tested the ability of tirasemtiv, a fast skeletal muscle troponin activator, to improve skeletal muscle function in a mouse model of NEM3, harboring the patient-based p.Asp286Gly variant in Acta1. Acute and long-term tirasemtiv treatment significantly increased muscle contractile capacity at submaximal stimulation frequencies in both fast-twitch extensor digitorum longus and gastrocnemius muscle, and intermediate-twitch diaphragm muscle in vitro and in vivo. Additionally, long-term tirasemtiv treatment in NEM3 mice resulted in a decreased respiratory rate with preserved minute volume, suggesting more efficient respiration. Altogether, our data support the therapeutic potential of fast skeletal muscle troponin activators in alleviating skeletal muscle weakness in a mouse model of NEM3 caused by the Acta1:p.Asp286Gly variant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Amsterdam UMC Location Vrije Universiteit Amsterdam, Physiology , Amsterdam, The Netherlands.
- Amsterdam Movement Sciences, Musculoskeletal Health and Tissue Function and Regeneration, Amsterdam, The Netherlands.
- Aix-Marseille University, CNRS, CRMBM , Marseille, France.
- Department of Molecular Medicine, University of Pavia, Pavia, Italy.
- Research and Early Development, Cytokinetics Inc. , South San Francisco, CA, USA.
- IRCCS Mondino Foundation , Pavia, Italy.
ORCID-Profile: Ricardo A Galli, Tamara C Borsboom, Charlotte Gineste, Lorenza Brocca, Maira Rossi, Darren T Hwee, Fady I Malik, Roberto Bottinelli, Julien Gondin, Maria-Antonietta Pellegrino, Josine M de Winter, Coen A C Ottenheijm
Förderung
- Netherlands Organisation for Health Research and Development
Zitieren
APA
Galli, R. A., Borsboom, T. C., Gineste, C., Brocca, L., Rossi, M., Hwee, D. T., Malik, F. I., Bottinelli, R., Gondin, J., Pellegrino, M. A., de Winter, J. M., & Ottenheijm, C. A. C. (2024). Tirasemtiv enhances submaximal muscle tension in an Acta1 :p.Asp286Gly mouse model of nemaline myopathy. Journal of General Physiology. https://doi.org/10.1085/jgp.202313471
Vancouver
Galli RA, Borsboom TC, Gineste C, Brocca L, Rossi M, Hwee DT, et al. Tirasemtiv enhances submaximal muscle tension in an Acta1 :p.Asp286Gly mouse model of nemaline myopathy. Journal of General Physiology. 2024. doi:10.1085/jgp.202313471
BibTeX
@article{Galli2024,
author = {Galli, Ricardo A and Borsboom, Tamara C and Gineste, Charlotte and Brocca, Lorenza and Rossi, Maira and Hwee, Darren T and Malik, Fady I and Bottinelli, Roberto and Gondin, Julien and Pellegrino, Maria-Antonietta and de Winter, Josine M and Ottenheijm, Coen A C},
title = {Tirasemtiv enhances submaximal muscle tension in an Acta1 :p.Asp286Gly mouse model of nemaline myopathy},
journal = {Journal of General Physiology},
year = {2024},
doi = {10.1085/jgp.202313471}
}
EUVIMED